Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Harvard Bioscience, Inc.    HBIO

HARVARD BIOSCIENCE, INC.

(HBIO)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/23/2020 11/24/2020 11/25/2020 11/27/2020 11/30/2020 Date
3.74(c) 3.68(c) 3.78(c) 3.87(c) 3.92(c) Last
160 105 189 837 50 173 49 943 68 204 Volume
-0.80% -1.60% +2.72% +2.38% +1.29% Change
More quotes
Financials (USD)
Sales 2020 98,2 M - -
Net income 2020 -7,65 M - -
Net Debt 2020 - - -
P/E ratio 2020 -20,1x
Yield 2020 -
Sales 2021 105 M - -
Net income 2021 0,40 M - -
Net Debt 2021 - - -
P/E ratio 2021 392x
Yield 2021 -
Capitalization 153 M 153 M -
Capi. / Sales 2020 1,56x
Capi. / Sales 2021 1,45x
Nbr of Employees 505
Free-Float 72,8%
More Financials
Company
Harvard Bioscience, Inc. is a developer, manufacturer and marketer of a range of scientific instruments, systems and lab consumables used for basic research, drug discovery, clinical and environmental testing. The Company's products are sold to thousands of researchers in over 100 countries through its global sales organization, Websites, catalogs and through distributors. The Company's product range is organized... 
More about the company
Notations Surperformance© of Harvard Bioscience, Inc.
Trading Rating : - Investor Rating :
More Ratings
All news about HARVARD BIOSCIENCE, INC.
11/18HARVARD BIOSCIENCE : HBIO Investor Presentation – November 2020
PU
11/16HARVARD BIOSCIENCE : to attend Benchmark's 9th Annual Discovery One-on-One Confe..
AQ
11/16Harvard Bioscience to attend Benchmark's 9th Annual Discovery One-on-One Conf..
GL
11/06HARVARD BIOSCIENCE : Management's Discussion and Analysis of Financial Condition..
AQ
11/05HARVARD BIOSCIENCE : 3Q Earnings Snapshot
AQ
11/05HARVARD BIOSCIENCE INC : Results of Operations and Financial Condition, Financia..
AQ
11/05HARVARD BIOSCIENCE : Announces Third Quarter 2020 Financial Results
AQ
11/05Harvard Bioscience Announces Third Quarter 2020 Financial Results
GL
10/20HARVARD BIOSCIENCE SCHEDULES THIRD Q : 00 am et
AQ
10/20HARVARD BIOSCIENCE SCHEDULES THIRD Q : 00 am et
GL
10/08HARVARD BIOSCIENCE : HBIO Investor Presentation – September 2020
PU
09/16HARVARD BIOSCIENCE : to Present at Singular Research Compelling Values Webinar
AQ
09/16Harvard Bioscience to Present at Singular Research Compelling Values Webinar
GL
08/10HARVARD BIOSCIENCE : Management's Discussion and Analysis of Financial Condition..
AQ
08/05HARVARD BIOSCIENCE : 2Q Earnings Snapshot
AQ
More news
News in other languages on HARVARD BIOSCIENCE, INC.
2013HARVARD BIOSCIENCE, INC. : publication des résultats trimestriels
2009HARVARD BIOSCIENCE : Harvard to cut 25 pct of investment unit's staff
More news
Analyst Recommendations on HARVARD BIOSCIENCE, INC.
More recommendations
Chart HARVARD BIOSCIENCE, INC.
Duration : Period :
Harvard Bioscience, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HARVARD BIOSCIENCE, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price 5,50 $
Last Close Price 3,92 $
Spread / Highest target 53,1%
Spread / Average Target 40,3%
Spread / Lowest Target 27,6%
EPS Revisions
Managers
NameTitle
James W. Green Chairman, President & Chief Executive Officer
Michael A. Rossi Chief Financial Officer
John F. Kennedy Independent Director
Bertrand Loy Lead Independent Director
Katherine A. Eade Independent Director
Sector and Competitors